TY - JOUR
T1 - Tumor-to-tumor metastasis
T2 - Lung adenocarcinoma into a clinically non-functioning gonadotroph pituitary adenoma: A rare case
AU - Sav, Aydın
AU - Altınöz, Meriç Adil
AU - Rotondo, Fabio
AU - Cykowski, Matthew
AU - Özer, Ali Fahir
AU - Kovacs, Kalman
N1 - Publisher Copyright:
© 2018, AVES İbrahim KARA. All rights reserved.
Copyright:
Copyright 2019 Elsevier B.V., All rights reserved.
PY - 2018/3
Y1 - 2018/3
N2 - We report a rare case of a metastatic lung adenocarcinoma to a clinically non-functioning pituitary gonadotroph adenoma in a 66-year-old male experiencing progressive headaches and diminished vision. Magnetic resonance imaging revealed a large tumor containing cystic cavity and acute hemorrhagic areas in the sella turcica and extending into the suprasellar cistern. Pathologic examination was consistent with a metastasizing lung adenocarcinoma to a clinically non-functioning pituitary adenoma. Immunohistochemistry revealed both pituitary adenoma and metastatic adenocarcinoma containing FSH and LH immunoreactive cells in the pituitary adenoma whereas napsin A, TTF-1, cytokeratin7, Pancytokeratin and galectin-3 immunopositivity were evidenced by adenocarcinoma cells within sinusoids and around blood vessels. The patient underwent a transthoracic fine needle biopsy that was positive for adenocarcinoma (Napsin-A positive, p63 negative). It was therefore concluded that the primary site for the sellar metastasis was in the lung. Primary metastasis to pituitary gland is rare with the most common primary sites include lung, breast, kidney and the gastrointestinal tract. Although rare, any case with progressive local pressure symptoms and endocrinologic stigmata with or without other signs of malignancy requires further examination to rule out pituitary metastasis.
AB - We report a rare case of a metastatic lung adenocarcinoma to a clinically non-functioning pituitary gonadotroph adenoma in a 66-year-old male experiencing progressive headaches and diminished vision. Magnetic resonance imaging revealed a large tumor containing cystic cavity and acute hemorrhagic areas in the sella turcica and extending into the suprasellar cistern. Pathologic examination was consistent with a metastasizing lung adenocarcinoma to a clinically non-functioning pituitary adenoma. Immunohistochemistry revealed both pituitary adenoma and metastatic adenocarcinoma containing FSH and LH immunoreactive cells in the pituitary adenoma whereas napsin A, TTF-1, cytokeratin7, Pancytokeratin and galectin-3 immunopositivity were evidenced by adenocarcinoma cells within sinusoids and around blood vessels. The patient underwent a transthoracic fine needle biopsy that was positive for adenocarcinoma (Napsin-A positive, p63 negative). It was therefore concluded that the primary site for the sellar metastasis was in the lung. Primary metastasis to pituitary gland is rare with the most common primary sites include lung, breast, kidney and the gastrointestinal tract. Although rare, any case with progressive local pressure symptoms and endocrinologic stigmata with or without other signs of malignancy requires further examination to rule out pituitary metastasis.
KW - Fsh/lh cell adenoma
KW - Gonadotroph cell adenoma
KW - Immunohistochemistry
KW - Metastatic lung adenocarcinoma
KW - Pathology
KW - Tumor-to-tumor metastasis
UR - http://www.scopus.com/inward/record.url?scp=85056625373&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85056625373&partnerID=8YFLogxK
U2 - 10.24165/jns.9865.16
DO - 10.24165/jns.9865.16
M3 - Article
AN - SCOPUS:85056625373
SN - 2636-865X
VL - 35
SP - 53
EP - 59
JO - Neurological Sciences and Neurophysiology
JF - Neurological Sciences and Neurophysiology
IS - 1
ER -